-
1
-
-
33748931490
-
Improving resectability of hepatic colorectal metastases: expert consensus statement
-
Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann. Surg. Oncol. 2006; 13: 1271-80.
-
(2006)
Ann. Surg. Oncol.
, vol.13
, pp. 1271-1280
-
-
Abdalla, E.K.1
Adam, R.2
Bilchik, A.J.3
Jaeck, D.4
Vauthey, J.N.5
Mahvi, D.6
-
2
-
-
2442704240
-
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases
-
discussion 25-7.
-
Abdalla EK, Vauthey JN, Ellis LM etal. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann. Surg. 2004; 239: 818-25; discussion 25-7.
-
(2004)
Ann. Surg.
, vol.239
, pp. 818-825
-
-
Abdalla, E.K.1
Vauthey, J.N.2
Ellis, L.M.3
-
3
-
-
0029794696
-
Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy
-
discussion 20-2.
-
Bismuth H, Adam R, Levi F etal. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann. Surg. 1996; 224: 509-20; discussion 20-2.
-
(1996)
Ann. Surg.
, vol.224
, pp. 509-520
-
-
Bismuth, H.1
Adam, R.2
Levi, F.3
-
4
-
-
0038600610
-
Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases
-
Adam R. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann. Oncol. 2003; 14 (Suppl 2): ii13-6.
-
(2003)
Ann. Oncol.
, vol.14
, Issue.SUPPL 2
-
-
Adam, R.1
-
5
-
-
44149107591
-
Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases
-
Gruenberger B, Scheithauer W, Punzengruber R, Zielinski C, Tamandl D, Gruenberger T. Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases. BMC Cancer 2008; 8: 120.
-
(2008)
BMC Cancer
, vol.8
, pp. 120
-
-
Gruenberger, B.1
Scheithauer, W.2
Punzengruber, R.3
Zielinski, C.4
Tamandl, D.5
Gruenberger, T.6
-
6
-
-
0041417909
-
Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver
-
Tanaka K, Adam R, Shimada H, Azoulay D, Levi F, Bismuth H. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br. J. Surg. 2003; 90: 963-9.
-
(2003)
Br. J. Surg.
, vol.90
, pp. 963-969
-
-
Tanaka, K.1
Adam, R.2
Shimada, H.3
Azoulay, D.4
Levi, F.5
Bismuth, H.6
-
7
-
-
9744226672
-
Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?
-
discussion 61-4.
-
Adam R, Pascal G, Castaing D etal. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann. Surg. 2004; 240: 1052-61; discussion 61-4.
-
(2004)
Ann. Surg.
, vol.240
, pp. 1052-1061
-
-
Adam, R.1
Pascal, G.2
Castaing, D.3
-
8
-
-
33644822617
-
Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note
-
Bilchik AJ, Poston G, Curley SA etal. Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J. Clin. Oncol. 2005; 23: 9073-8.
-
(2005)
J. Clin. Oncol.
, vol.23
, pp. 9073-9078
-
-
Bilchik, A.J.1
Poston, G.2
Curley, S.A.3
-
9
-
-
42249100008
-
Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases
-
Covey AM, Brown KT, Jarnagin WR etal. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann. Surg. 2008; 247: 451-5.
-
(2008)
Ann. Surg.
, vol.247
, pp. 451-455
-
-
Covey, A.M.1
Brown, K.T.2
Jarnagin, W.R.3
-
10
-
-
40749107362
-
Perioperative chemotherapy for resectable hepatic metastases
-
Kopetz S, Vauthey JN. Perioperative chemotherapy for resectable hepatic metastases. Lancet 2008; 371: 963-5.
-
(2008)
Lancet
, vol.371
, pp. 963-965
-
-
Kopetz, S.1
Vauthey, J.N.2
-
11
-
-
34347234594
-
Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome
-
Pawlik TM, Olino K, Gleisner AL, Torbenson M, Schulick R, Choti MA. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J. Gastrointest. Surg. 2007; 11: 860-8.
-
(2007)
J. Gastrointest. Surg.
, vol.11
, pp. 860-868
-
-
Pawlik, T.M.1
Olino, K.2
Gleisner, A.L.3
Torbenson, M.4
Schulick, R.5
Choti, M.A.6
-
12
-
-
33846309211
-
Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes
-
Sahajpal A, Vollmer CM, Jr, Dixon E etal. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes. J. Surg. Oncol. 2007; 95: 22-7.
-
(2007)
J. Surg. Oncol.
, vol.95
, pp. 22-27
-
-
Sahajpal, A.1
Vollmer Jr, C.M.2
Dixon, E.3
-
13
-
-
33747077466
-
Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases
-
Capussotti L, Muratore A, Mulas MM, Massucco P, Aglietta M. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases. Br. J. Surg. 2006; 93: 1001-6.
-
(2006)
Br. J. Surg.
, vol.93
, pp. 1001-1006
-
-
Capussotti, L.1
Muratore, A.2
Mulas, M.M.3
Massucco, P.4
Aglietta, M.5
-
14
-
-
19744365905
-
Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases
-
Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J. Am. Coll. Surg. 2005; 200: 845-53.
-
(2005)
J. Am. Coll. Surg.
, vol.200
, pp. 845-853
-
-
Fernandez, F.G.1
Ritter, J.2
Goodwin, J.W.3
Linehan, D.C.4
Hawkins, W.G.5
Strasberg, S.M.6
-
15
-
-
33750961459
-
Benefits and risks of neoadjuvant therapy for liver metastases
-
Nordlinger B, Benoist S. Benefits and risks of neoadjuvant therapy for liver metastases. J. Clin. Oncol. 2006; 24: 4954-5.
-
(2006)
J. Clin. Oncol.
, vol.24
, pp. 4954-4955
-
-
Nordlinger, B.1
Benoist, S.2
-
16
-
-
42949130734
-
Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer
-
Gruenberger B, Tamandl D, Schueller J etal. Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. J. Clin. Oncol. 2008; 26: 1830-5.
-
(2008)
J. Clin. Oncol.
, vol.26
, pp. 1830-1835
-
-
Gruenberger, B.1
Tamandl, D.2
Schueller, J.3
-
17
-
-
44849083292
-
Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases
-
White RR, Schwartz LH, Munoz JA etal. Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases. J. Surg. Oncol. 2008; 97: 601-4.
-
(2008)
J. Surg. Oncol.
, vol.97
, pp. 601-604
-
-
White, R.R.1
Schwartz, L.H.2
Munoz, J.A.3
-
18
-
-
33846641607
-
Preoperative chemotherapy and the outcome of liver resection for colorectal metastases
-
discussion 65-6.
-
Hewes JC, Dighe S, Morris RW, Hutchins RR, Bhattacharya S, Davidson BR. Preoperative chemotherapy and the outcome of liver resection for colorectal metastases. World J. Surg. 2007; 31: 353-64; discussion 65-6.
-
(2007)
World J. Surg.
, vol.31
, pp. 353-364
-
-
Hewes, J.C.1
Dighe, S.2
Morris, R.W.3
Hutchins, R.R.4
Bhattacharya, S.5
Davidson, B.R.6
-
19
-
-
62849128239
-
Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases
-
Chun YS, Laurent A, Maru D, Vauthey JN. Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases. Lancet Oncol. 2009; 10: 278-86.
-
(2009)
Lancet Oncol.
, vol.10
, pp. 278-286
-
-
Chun, Y.S.1
Laurent, A.2
Maru, D.3
Vauthey, J.N.4
-
20
-
-
30144435398
-
Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases
-
Karoui M, Penna C, Amin-Hashem M etal. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann. Surg. 2006; 243: 1-7.
-
(2006)
Ann. Surg.
, vol.243
, pp. 1-7
-
-
Karoui, M.1
Penna, C.2
Amin-Hashem, M.3
-
21
-
-
33750957147
-
Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases
-
Aloia T, Sebagh M, Plasse M etal. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J. Clin. Oncol. 2006; 24: 4983-90.
-
(2006)
J. Clin. Oncol.
, vol.24
, pp. 4983-4990
-
-
Aloia, T.1
Sebagh, M.2
Plasse, M.3
-
22
-
-
0037267766
-
Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases
-
discussion 16-7.
-
Allen PJ, Kemeny N, Jarnagin W, DeMatteo R, Blumgart L, Fong Y. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J. Gastrointest. Surg. 2003; 7: 109-15; discussion 16-7.
-
(2003)
J. Gastrointest. Surg.
, vol.7
, pp. 109-115
-
-
Allen, P.J.1
Kemeny, N.2
Jarnagin, W.3
DeMatteo, R.4
Blumgart, L.5
Fong, Y.6
-
23
-
-
0033637804
-
Preoperative systemic 5-fluorouracil does not increase the risk of liver resection
-
Parc Y, Dugue L, Farges O, Hiramatsu K, Sauvanet A, Belghiti J. Preoperative systemic 5-fluorouracil does not increase the risk of liver resection. Hepatogastroenterology 2000; 47: 1703-5.
-
(2000)
Hepatogastroenterology
, vol.47
, pp. 1703-1705
-
-
Parc, Y.1
Dugue, L.2
Farges, O.3
Hiramatsu, K.4
Sauvanet, A.5
Belghiti, J.6
-
24
-
-
0024397765
-
Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure
-
Didolkar MS, Fitzpatrick JL, Elias EG etal. Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure. Surg. Gynecol. Obstet. 1989; 169: 17-26.
-
(1989)
Surg. Gynecol. Obstet.
, vol.169
, pp. 17-26
-
-
Didolkar, M.S.1
Fitzpatrick, J.L.2
Elias, E.G.3
-
25
-
-
3843062418
-
Extent of hepatic resection does not correlate with toxicity following adjuvant chemotherapy
-
Carlo WF, Hummer AJ, Schwartz L etal. Extent of hepatic resection does not correlate with toxicity following adjuvant chemotherapy. J. Surg. Oncol. 2004; 87: 85-90.
-
(2004)
J. Surg. Oncol.
, vol.87
, pp. 85-90
-
-
Carlo, W.F.1
Hummer, A.J.2
Schwartz, L.3
-
26
-
-
63649164527
-
Liver failure after major hepatic resection
-
doi:10.1007/s00534-008-0017-y.
-
Garcea G, Maddern GJ. Liver failure after major hepatic resection. J. Hepatobiliary Pancreat Surg. 2008; doi:10.1007/s00534-008-0017-y.
-
(2008)
J. Hepatobiliary Pancreat Surg.
-
-
Garcea, G.1
Maddern, G.J.2
-
27
-
-
40749149728
-
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
-
Nordlinger B, Sorbye H, Glimelius B etal. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371: 1007-16.
-
(2008)
Lancet
, vol.371
, pp. 1007-1016
-
-
Nordlinger, B.1
Sorbye, H.2
Glimelius, B.3
-
28
-
-
34249328503
-
Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study
-
McCormack L, Petrowsky H, Jochum W, Furrer K, Clavien PA. Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann. Surg. 2007; 245: 923-30.
-
(2007)
Ann. Surg.
, vol.245
, pp. 923-930
-
-
McCormack, L.1
Petrowsky, H.2
Jochum, W.3
Furrer, K.4
Clavien, P.A.5
-
29
-
-
0032057111
-
Hepatic steatosis as a potential risk factor for major hepatic resection
-
Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J. Gastrointest. Surg. 1998; 2: 292-8.
-
(1998)
J. Gastrointest. Surg.
, vol.2
, pp. 292-298
-
-
Behrns, K.E.1
Tsiotos, G.G.2
DeSouza, N.F.3
Krishna, M.K.4
Ludwig, J.5
Nagorney, D.M.6
-
31
-
-
36348974014
-
Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis
-
Gomez D, Malik HZ, Bonney GK etal. Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br. J. Surg. 2007; 94: 1395-402.
-
(2007)
Br. J. Surg.
, vol.94
, pp. 1395-1402
-
-
Gomez, D.1
Malik, H.Z.2
Bonney, G.K.3
-
32
-
-
10744231437
-
Impact of steatosis on perioperative outcome following hepatic resection
-
Kooby DA, Fong Y, Suriawinata A etal. Impact of steatosis on perioperative outcome following hepatic resection. J. Gastrointest. Surg. 2003; 7: 1034-44.
-
(2003)
J. Gastrointest. Surg.
, vol.7
, pp. 1034-1044
-
-
Kooby, D.A.1
Fong, Y.2
Suriawinata, A.3
-
34
-
-
4644320061
-
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival
-
discussion 57-8.
-
Adam R, Delvart V, Pascal G etal. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann. Surg. 2004; 240: 644-57; discussion 57-8.
-
(2004)
Ann. Surg.
, vol.240
, pp. 644-657
-
-
Adam, R.1
Delvart, V.2
Pascal, G.3
-
35
-
-
51749125769
-
Effect of preoperative chemotherapy on liver resection for colorectal liver metastases
-
Mehta NN, Ravikumar R, Coldham CA etal. Effect of preoperative chemotherapy on liver resection for colorectal liver metastases. Eur. J. Surg. Oncol. 2008; 34: 782-6.
-
(2008)
Eur. J. Surg. Oncol.
, vol.34
, pp. 782-786
-
-
Mehta, N.N.1
Ravikumar, R.2
Coldham, C.A.3
-
36
-
-
43449126960
-
Pathological analysis of hepatic injury after oxaliplatin-based neoadjuvant chemotherapy of colorectal cancer liver metastases: results of the EORTC Intergroup phase III study 40983
-
abstr 241
-
Julie C, Lutz M, Aust D etal. Pathological analysis of hepatic injury after oxaliplatin-based neoadjuvant chemotherapy of colorectal cancer liver metastases: results of the EORTC Intergroup phase III study 40983. J. Clin. Oncol. 2007; 25: (abstr 241).
-
(2007)
J. Clin. Oncol.
, vol.25
-
-
Julie, C.1
Lutz, M.2
Aust, D.3
-
37
-
-
78751667108
-
Liver resection in obese patients: results of a case-control study
-
Vigano L, Kluger MD, Laurent A etal. Liver resection in obese patients: results of a case-control study. HPB (Oxford) 2011; 13: 103-11.
-
(2011)
HPB (Oxford)
, vol.13
, pp. 103-111
-
-
Vigano, L.1
Kluger, M.D.2
Laurent, A.3
-
38
-
-
0033922244
-
Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection
-
Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J. Am. Coll. Surg. 2000; 191: 38-46.
-
(2000)
J. Am. Coll. Surg.
, vol.191
, pp. 38-46
-
-
Belghiti, J.1
Hiramatsu, K.2
Benoist, S.3
Massault, P.4
Sauvanet, A.5
Farges, O.6
-
39
-
-
0026751233
-
Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies
-
Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 1992; 53: 957-78.
-
(1992)
Transplantation
, vol.53
, pp. 957-978
-
-
Clavien, P.A.1
Harvey, P.R.2
Strasberg, S.M.3
-
40
-
-
43449090668
-
Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases
-
Morris-Stiff G, Tan YM, Vauthey JN. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur. J. Surg. Oncol. 2008; 34: 609-14.
-
(2008)
Eur. J. Surg. Oncol.
, vol.34
, pp. 609-614
-
-
Morris-Stiff, G.1
Tan, Y.M.2
Vauthey, J.N.3
-
41
-
-
0034655695
-
Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation
-
Marcos A, Fisher RA, Ham JM etal. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000; 69: 1375-9.
-
(2000)
Transplantation
, vol.69
, pp. 1375-1379
-
-
Marcos, A.1
Fisher, R.A.2
Ham, J.M.3
-
42
-
-
63649142566
-
Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases
-
doi:10.1007/s00534-008-0016-z.
-
Khan AZ, Morris-Stiff G, Makuuchi M. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J. Hepatobiliary Pancreat Surg. 2008; doi:10.1007/s00534-008-0016-z.
-
(2008)
J. Hepatobiliary Pancreat Surg.
-
-
Khan, A.Z.1
Morris-Stiff, G.2
Makuuchi, M.3
-
43
-
-
33646021275
-
Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired
-
Cho JY, Suh KS, Kwon CH, Yi NJ, Lee KU. Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired. Surgery 2006; 139: 508-15.
-
(2006)
Surgery
, vol.139
, pp. 508-515
-
-
Cho, J.Y.1
Suh, K.S.2
Kwon, C.H.3
Yi, N.J.4
Lee, K.U.5
-
44
-
-
0036729447
-
The utility of radiological imaging in nonalcoholic fatty liver disease
-
Saadeh S, Younossi ZM, Remer EM etal. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-50.
-
(2002)
Gastroenterology
, vol.123
, pp. 745-750
-
-
Saadeh, S.1
Younossi, Z.M.2
Remer, E.M.3
-
45
-
-
33646457231
-
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
-
Vauthey JN, Pawlik TM, Ribero D etal. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J. Clin. Oncol. 2006; 24: 2065-72.
-
(2006)
J. Clin. Oncol.
, vol.24
, pp. 2065-2072
-
-
Vauthey, J.N.1
Pawlik, T.M.2
Ribero, D.3
-
46
-
-
34247216060
-
Chemotherapy-induced steatohepatitis in colorectal cancer patients
-
author reply -8.
-
Gentilucci UV, Santini D, Vincenzi B, Fiori E, Picardi A, Tonini G. Chemotherapy-induced steatohepatitis in colorectal cancer patients. J. Clin. Oncol. 2006; 24: 5467; author reply -8.
-
(2006)
J. Clin. Oncol.
, vol.24
, pp. 5467
-
-
Gentilucci, U.V.1
Santini, D.2
Vincenzi, B.3
Fiori, E.4
Picardi, A.5
Tonini, G.6
-
47
-
-
28044446543
-
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease
-
Hamaguchi M, Kojima T, Takeda N etal. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. Intern. Med. 2005; 143: 722-8.
-
(2005)
Ann. Intern. Med.
, vol.143
, pp. 722-728
-
-
Hamaguchi, M.1
Kojima, T.2
Takeda, N.3
-
48
-
-
37549068554
-
Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy
-
Nakano H, Oussoultzoglou E, Rosso E etal. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann. Surg. 2008; 247: 118-24.
-
(2008)
Ann. Surg.
, vol.247
, pp. 118-124
-
-
Nakano, H.1
Oussoultzoglou, E.2
Rosso, E.3
-
49
-
-
11144354740
-
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
-
Rubbia-Brandt L, Audard V, Sartoretti P etal. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann. Oncol. 2004; 15: 460-6.
-
(2004)
Ann. Oncol.
, vol.15
, pp. 460-466
-
-
Rubbia-Brandt, L.1
Audard, V.2
Sartoretti, P.3
-
50
-
-
0036125693
-
Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease)
-
DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin. Liver Dis. 2002; 22: 27-42.
-
(2002)
Semin. Liver Dis.
, vol.22
, pp. 27-42
-
-
DeLeve, L.D.1
Shulman, H.M.2
McDonald, G.B.3
-
51
-
-
0037775811
-
Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases
-
discussion 9-70.
-
Kooby DA, Stockman J, Ben-Porat L etal. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann. Surg. 2003; 237: 860-9; discussion 9-70.
-
(2003)
Ann. Surg.
, vol.237
, pp. 860-869
-
-
Kooby, D.A.1
Stockman, J.2
Ben-Porat, L.3
|